Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem. The European Medicines Agency (EMA) coordinates the European Union (EU) pharmacovigilance system and sets rules and guidelines to…
Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects and other drug-related problems. It is an important component of the post-marketing surveillance program of medicinal products and medical devices as…
Ensuring the safety and efficacy of new drugs, medical devices, and biological products does not end once the treatment is approved or is on the market but extends to the post-marketing phase. Since the overarching goal of all new approvals…
Pharmacovigilance is defined by the World Health Organization (WHO) as “the science and activities relating to the detection, assessment, understanding, and prevention of adverse events or any other drug-related problems.” Drug pharmacovigilance programs form an important part of post-marketing risk…
The global Pharmacovigilance market size is expected to reach $ 11.64 billion by 2026 and it is projected to expand at a CAGR of 13.3 during the coming years. Pharmacovigilance is the science and activities involved in the detection, understanding,…
Researchers agree that the highest standards in clinical research need to be preserved to maintain the public’s confidence in their work, competence, and ethics. With patient safety as a primary consideration, the implementation of safety monitoring is paramount. One means…